Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological management--inhaled treatment.

× No keyword cloud information.

9 in total

1. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors: B R Celli; W MacNee
Journal: Eur Respir J Date: 2004-06 Impact factor: 16.671

Review 2. Management of chronic obstructive pulmonary disease.

Authors: E Rand Sutherland; Reuben M Cherniack
Journal: N Engl J Med Date: 2004-06-24 Impact factor: 91.245

3. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors: P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal: BMJ Date: 2000-05-13

4. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.

Authors: J Vestbo; T Sørensen; P Lange; A Brix; P Torre; K Viskum
Journal: Lancet Date: 1999-05-29 Impact factor: 79.321

Review 5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors: R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal: Am J Respir Crit Care Med Date: 2001-04 Impact factor: 21.405

6. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.

Authors: Robert Wise; John Connett; Gail Weinmann; Paul Scanlon; Melissa Skeans
Journal: N Engl J Med Date: 2000-12-28 Impact factor: 91.245

Review 7. Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease.

Authors: Graeme P Currie; Catherine Rossiter; Sean A Miles; Daniel K C Lee; Owen J Dempsey
Journal: Pulm Pharmacol Ther Date: 2005-06-20 Impact factor: 3.410

Review 8. Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation.

Authors: S Appleton; P Poole; B Smith; A Veale; A Bara
Journal: Cochrane Database Syst Rev Date: 2002

9. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors:
Journal: Thorax Date: 2004-02 Impact factor: 9.139

9 in total

3 in total

Review 1. Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment.

Authors: Graeme P Currie; Claire A Butler; Wendy J Anderson; Chris Skinner
Journal: Br J Clin Pharmacol Date: 2008-03-13 Impact factor: 4.335

2. Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database.

Authors: Michele Jara; Stephan F Lanes; Charles Wentworth; Corey May; Steven Kesten
Journal: Drug Saf Date: 2007 Impact factor: 5.606

Review 3. Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.

Authors: Antonio Molino; Giovanna Calabrese; Mauro Maniscalco
Journal: Patient Prefer Adherence Date: 2018-06-08 Impact factor: 2.711

3 in total